SaO030EFFICACY AND SAFETY OF LOW DOSE VERSUS FULL DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
Author(s) -
Medhat A Halim,
Torki Al-Otaibi,
Osama Gheith,
Hany Adel,
Ahmed Mosaad,
Hassaneen Abo-Atteya,
Zakaria Zakaria,
Tarek Said,
Prasad Nair,
M.R.N. Nampoory
Publication year - 2015
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfv151.02
Subject(s) - medicine , valganciclovir , cytomegalovirus , kidney transplant , kidney disease , urology , ganciclovir , kidney transplantation , intensive care medicine , kidney , surgery , immunology , human cytomegalovirus , herpesviridae , viral disease , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom